Amplius Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
14,251
+3,966
+39% +$104K 0.03% 161
2026
Q1
$289K Sell
10,285
-153
-1% -$4.07K 0.02% 147
2025
Q4
$260K Sell
10,438
-32,854
-76% -$828K 0.02% 149
2025
Q3
$1.1M Sell
43,292
-3,114
-7% -$76.9K 0.1% 67
2025
Q2
$1.12M Sell
46,406
-136
-0.3% -$3.17K 0.1% 75
2025
Q1
$1.18M Sell
46,542
-281
-0.6% -$7.35K 0.12% 69
2024
Q4
$1.24M Buy
46,823
+20,911
+81% +$567K 0.13% 66
2024
Q3
$750K Sell
25,912
-104
-0.4% -$3.03K 0.08% 79
2024
Q2
$728K Sell
26,016
-1,948
-7% -$53.6K 0.08% 81
2024
Q1
$776K Buy
27,964
+313
+1% +$8.69K 0.09% 80
2023
Q4
$796K Sell
27,651
-7,453
-21% -$225K 0.1% 74
2023
Q3
$1.16M Sell
35,104
-1,072
-3% -$37.9K 0.16% 61
2023
Q2
$1.33M Buy
36,176
+455
+1% +$17.7K 0.18% 60
2023
Q1
$1.46M Buy
35,721
+1,532
+4% +$66.2K 0.21% 55
2022
Q4
$1.75M Buy
34,189
+1,720
+5% +$82.5K 0.28% 51
2022
Q3
$1.42M Buy
32,469
+732
+2% +$35.6K 0.25% 50
2022
Q2
$1.66M Sell
31,737
-279
-0.9% -$14.2K 0.27% 49
2022
Q1
$1.66M Sell
32,016
-773
-2% -$40.1K 0.25% 48
2021
Q4
$1.94M Buy
+32,789
New +$1.62M 0.27% 46

Other funds holding PFE

Amplius Wealth Advisors's PFE Position: Q2 2026 in Review

Amplius Wealth Advisors increased its Pfizer (PFE) stake by 39% in Q2 2026, buying an estimated $104K and bringing the position to 14,251 shares worth $343K. The position accounts for 0.03% of the portfolio, ranked #161.

Amplius Wealth Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.94M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Amplius Wealth Advisors held 14,251 shares of Pfizer worth $343K as of Q2 2026.
  • Amplius Wealth Advisors bought 3,966 Pfizer shares in Q2 2026, an estimated $104K.
  • Pfizer made up 0.03% of Amplius Wealth Advisors's portfolio in Q2 2026, its #161 holding.
  • Amplius Wealth Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Amplius Wealth Advisors's Pfizer position peaked at $1.94M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Amplius Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.